Field: Infectious diseases

Location: UQ Centre for Clinical Research (Herston)

Type of student: Both PhD/MPhil and Volunteer

Type of work: Wet lab work

Prerequisite skills: Good writing skills, organized and keen to learn

Brief synopsis: We are currently developing probiotics capable in decolonizing antibiotic resistant bacteria from gastrointestinal tract (GIT). This strategy will provide an alternative to antibiotics as a strategy to decolonize antibiotic resistant bacteria from GIT. Hopefully, this will indirectly reduce the use of antibiotics in the community. Antibiotic resistance is one of the most pressing health concerns worldwide and in Australia. Infections by antibiotic resistant bacteria complicate treatment options. Colonization by antibiotic resistant bacteria in GIT can cause recurrent infections. Normal bacterial flora or commensals protect mucosal membranes from the invasion by pathogens. We have screened commensals isolated from the Australian population for use as probiotics and tested our these against various pathogens causing nosocomial, urinary tract and blood stream infections. Here, we aim to be able to define the dose of oral probiotic administration in a clinical trial. Your role will be to assist me in developing the ethics application. You will also have the opportunity to do simple laboratory testing.

Time frame: 4 September 2017 - 28 February 2018


Dr Hanna Sidjabat

Dr Hanna Sidjabat

Chief Investigator
UQ Centre for Clinical Research